Article metrics
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
845 A colony stimulating factor 1 receptor-blocking bifunctional protein simultaneously targets tumor-associated macrophages and exhausted T cells for the treatment of triple-negative breast cancer